Relmada Therapeutics(RLMD)
CORAL GABLES, FLBiotechnology
Focus: Relmada Therapeutics is a public biotech company focused on small molecules for pain, oncology, and neurology, with a pipeline centered on REL-1017 for depression and NDV-01 for bladder cancer. The company operates at a 5,000+ employee scale from Coral Gables, Florida.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
About Relmada Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Relmada Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Relmada Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
REL-1017
Major Depressive DisorderClinical Trials (1)
NCT06009003Individual Patient Esmethadone (REL-1017) Expanded Access Program
N/AHelp build intelligence for Relmada Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.